FIELD: medicine. SUBSTANCE: method involves per os additionally administering clodronate (bonephos) in the amount of 11.2-16 g or 2.1-4.2 g in intravenous application during 7-10 days before applying radiation therapy. Daily per oral clodronate (bonephos) administration is indicated twice a day in the amount of 800 mg during the whole radiation therapy course and during three following months. The radiation therapy is applied as intensive concentrated treatment in applying focal daily dose of 4-5 Gr every day until the total course dose in the focus reaches 20-25 Gr. EFFECT: enhanced effectiveness of treatment course; accelerated treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING OSSEOUS METASTASIS | 2003 |
|
RU2241452C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM LOCALLY SPREAD FORMS OF CANCER | 1994 |
|
RU2098154C1 |
| METHOD OF TREATMENT OF PATIENT WITH OSTEOLYTIC METASTASIS | 1999 |
|
RU2153358C1 |
| METHOD FOR TREATMENT OF ONCOLOGICAL PATIENTS | 2002 |
|
RU2234916C2 |
| METHOD FOR TREATING PATIENTS POSSESSING CEREBRAL TUMOR | 1997 |
|
RU2125871C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LOCALLY SPREAD CANCER FORMS | 1993 |
|
RU2088288C1 |
| METHOD OF TREATING SPINE TUMOURS | 2014 |
|
RU2551622C1 |
| METHOD FOR TREATMENT OF PLURAL OSTEAL METASTASISES DURING MAMMARY GLAND CANCER | 2007 |
|
RU2332992C1 |
| METHOD OF TREATMENT OF UNRESECTABLE PANCREATICODUODENAL CANCER | 2007 |
|
RU2341308C1 |
| METHOD OF TREATING RECTAL CANCER | 2010 |
|
RU2424013C1 |
